Bromination Pattern of Hydroxylated Metabolites of BDE-47 Affects Their Potency to Release Calcium from Intracellular Stores in PC12 Cells by Dingemans, Milou M.L. et al.
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 4 | April 2010  519
Research
Brominated flame retardants are added to a 
wide array of consumer products. Adverse 
effects of these compounds on the developing 
nervous system give cause for concern (for 
review, see Costa and Giordano 2007). Long-
lasting neurobehavioral changes after neo  natal 
exposure have been detected in rodents after 
exposure to poly  brominated diphenyl ethers 
(PBDEs) (Branchi et al. 2003; Eriksson et al. 
2001; Lilienthal et al. 2006; Rice et al. 2007; 
Viberg et al. 2003, 2006), as well as various 
functional and structural alterations in the 
brain (Dingemans et al. 2007; Viberg 2009; 
Xing et al. 2009).
During development, acute effects on 
neuronal activity may result in long-lasting 
changes in proteins, brain function, and behav-
ior. A key regulator for neuronal function is 
intracellular concentration of calcium ions, 
[Ca2+]i, which regulates many cellular pro-
cesses, including the release of neurotransmit-
ters at the pre  synaptic terminal (for reviews, see 
Clapham 2007; Laude and Simpson 2009). 
PBDEs have been shown to affect Ca2+ 
homeo  stasis in microsomes (Kodavanti and 
Ward 2005) and pheochromocytoma (PC12) 
cells (Dingemans et al. 2007) and to reduce 
the Ca2+ uptake by brain microsomes and 
mitochondria (Coburn et al. 2008) at rela-
tively high concentrations. PBDEs have also 
been shown to induce oxidative stress in neu-
ronal cells (He et al. 2008; Kodavanti and 
Ward 2005). Recently, 6-OH-BDE-47 
(6-hydroxy-2,2´,4,4´-tetra  bromo  diphenyl 
ether), a hydroxylated metabolite of BDE-47 
(2,2´,4,4´-tetrabromo  diphenyl ether), was 
demon  strated to increase vesicular neurotrans-
mitter release and [Ca2+]i by releasing Ca2+ 
from intra  cellular stores in PC12 cells. The 
increase in vesicular neuro  transmitter release 
was induced by 6-OH-BDE-47 at much 
lower concentrations than by the parent 
PBDE (Dingemans et al. 2008). Therefore, 
hydroxylated PBDEs (OH-PBDEs) may be 
more important than the parent compounds 
for human risk assessment for neurotoxicity.
Recently, not only PBDEs but also vari-
ous hydroxylated metabolites of PBDEs have 
been found to bio  accumulate in humans 
(Athanasiadou et al. 2008; Qiu et al. 2009). 
Therefore, the aim of the present study was 
to determine whether mono  hydroxylated 
metabolites of the abundant BDE-47 affect 
[Ca2+]i and to compare this with the effects of 
a methoxylated analog and several other envi-
ronmentally relevant PBDE congeners.
Materials and Methods
Chemicals. In the present study, we investigated 
the effects of BDE-47, BDE-99 (2,2´,4,4´,5-
penta  bromo  diphenyl ether), BDE-100 
(2,2´,4,4´,6-penta  bromo  diphenyl ether), and 
BDE-153 (2,2´,4,4´,5,5´-hexa  bromo  diphenyl 
ether), the main constituents of the commer-
cial DE-71 pentaBDE mixture (La Guardia 
et al. 2006), as well as several metabolites of 
BDE-47 [6-OH-BDE-47, 6´-OH-BDE-49 
(6´-hydroxy-2,2´,4,5´-tetrabromodiphenyl 
ether), 5-OH-BDE-47 (5-hydroxy-2,2´,4,4´-
tetrabromodiphenyl ether), 3-OH-BDE-47 
(3-hydroxy-2,2´,4,4´-tetrabromodiphenyl 
ether),  4´-OH-BDE-49  (4´-hydroxy-
2,2´,4,5´-tetrabromodiphenyl ether), and 
the methoxylated analog 6-MeO-BDE-47 
(6-methoxy-2,2´,4,4´-tetrabromodiphenyl 
ether)]. During formation of 6´-OH-BDE-49 
and 4´-OH-BDE-49, a bromine (Br)-shift takes 
place. Consequently, we included BDE-49 
(2,2´,4,5´-tetrabromo  diphenyl ether) as a con-
trol for possible influences of this change in 
bromination pattern.
PBDEs (Figure 1) [see also Supplemental 
Material, Table 1 (doi:10.1289/ehp.0901339)] 
were synthesized and purified (~ 99% 
purity) at the Department of Environmental 
Chemistry, Stockholm University (Marsh et al. 
1999). Dibenzo-p-dioxins and dibenzofurans 
were removed from the PBDEs with a charcoal 
column as described by Örn et al. (1996). All 
other chemicals, unless otherwise stated, were 
obtained from Sigma-Aldrich (Zwijndrecht, 
the Netherlands).
Cell culture. Rat pheochromo  cytoma 
(PC12) cells (Greene and Tischler 1976), 
obtained from ATCC (American Type 
Culture Collection, Manassas, VA, USA), were 
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Ba c k g r o u n d: Brominated flame retardants, including the widely used polybrominated diphenyl 
ethers (PBDEs), have been detected in humans, raising concern about possible neurotoxicity. Recent 
research demonstrated that the hydroxylated metabolite 6-OH-BDE-47 increases neuro  transmitter 
release by releasing calcium ions (Ca2+) from intra  cellular stores at much lower concentrations than 
its environmentally relevant parent congener BDE-47. Recently, several other hydroxylated BDE-47 
metabolites, besides 6-OH-BDE-47, have been detected in human serum and cord blood. 
oB j e c t i v e a n d Me t h o d s : To investigate the neurotoxic potential of other environmentally 
relevant PBDEs and their metabolites, we examined and compared the acute effects of BDE-47, 
BDE-49, BDE-99, BDE-100, BDE-153, and several metabolites of BDE-47—6-OH-BDE-47 (and 
its methoxylated analog 6-MeO-BDE-47), 6´-OH-BDE-49, 5-OH-BDE-47, 3-OH-BDE-47, and 
4´-OH-BDE-49—on intra  cellular Ca2+ concentration ([Ca2+]i), measured using the Ca2+-responsive 
dye Fura-2 in neuroendocrine pheochromocytoma (PC12) cells. 
re s u l t s: In contrast to the parent PBDEs and 6-MeO-BDE-47, all hydroxylated metabolites induced 
Ca2+ release from intracellular stores, although with different lowest observed effect concentrations 
(LOECs). The major intracellular Ca2+ sources were either endoplasmic reticulum (ER; 5-OH-
BDE-47 and 6´-OH-BDE-49) or both ER and mitochondria (6-OH-BDE-47, 3-OH-BDE-47, and 
4´-OH-BDE-49). When investigating fluctuations in [Ca2+]i, which is a more subtle end point, we 
observed lower LOECs for 6-OH-BDE-47 and 4´-OH-BDE-49, as well as for BDE-47. 
co n c l u s i o n s: The present findings demonstrate that hydroxylated metabolites of BDE-47 cause 
disturbance of the [Ca2+]i. Importantly, shielding of the OH group on both sides with bromine 
atoms and/or the ether bond to the other phenyl ring lowers the potency of hydroxylated PBDE 
metabolites.
key w o r d s : brominated flame retardant, calcium, calcium fluctuations, Fura-2, intracellular calcium 
stores, neurotoxicity, PC12, persistent organic pollutant, polybrominated diphenyl ether, structure–
activity relationship. Environ Health Perspect 118:519–525 (2010).  doi:10.1289/ehp.0901339 avail-
able via http://dx.doi.org/ [Online 19 November 2009]Dingemans et al.
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cultured as described previously [Dingemans 
et al. 2008; see also Supplemental Material 
(doi:10.1289/ehp.0901339)].
Cell viability assay. To investigate pos-
sible acute effects of the PBDEs on cell viabil-
ity, we used the alamarBlue (AB) and neutral 
red (NR) uptake assays with minor modifica-
tions [Magnani and Bettini 2000; Repetto 
et al. 2008; see also Supplemental Material 
(doi:10.1289/ehp.0901339)].
Intracellular Ca2+ imaging. Changes in 
[Ca2+]i were measured using the Ca2+-sensitive 
fluorescence ratio dye Fura-2 as described pre-
viously (Dingemans et al. 2007, 2008). For 
detailed information on experimental conditions 
and calculation of [Ca2+]i, see Supplemental 
Material (doi:10.1289/ehp.0901339).
The average and amplitude of [Ca2+]i dur-
ing exposure were determined per cell to inves-
tigate effects of PBDEs on Ca2+ homeo  stasis. 
The standard deviation during baseline [Ca2+]i 
recording ranged from 2% to 74% of average 
[Ca2+]i [n = 1,538; see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0901339)]. To 
prevent registration of false-positive effects, 
an increase in [Ca2+]i to > 175% of baseline 
was used to determine no observed effect con-
centrations (NOECs) and lowest observed 
effect concentrations (LOECs). A transient 
increase within 0–10 min from the start of 
exposure is referred to as an “initial increase,” 
whereas additional increases are referred to as 
“late increases” (Dingemans et al. 2008). At 
NOEC levels, based on average and ampli-
tude of [Ca2+]i levels, increases in [Ca2+]i lev-
els to > 175% of baseline during exposure 
were scored as fluctuations to investigate 
more subtle effects on Ca2+ homeostasis. 
We determined the number of cells showing 
fluctuations in [Ca2+]i, as well as frequency, 
amplitude, and duration of these fluctuations. 
Data analysis and statistics. All data are 
presented as mean ± SE from the number of 
cells or fluctuations in [Ca2+]i. We performed 
statistical analyses using SPSS 16 (SPSS, 
Chicago, IL, USA). Categorical and con-
tinuous data were compared using Fisher’s 
exact test and Student’s t-test, respectively, 
paired or unpaired where applicable. Analysis 
of variance (ANOVA) and post hoc t-tests 
were performed to investigate possible dose–
response relationships. To investigate struc-
ture–activity relationships, we investigated the 
possible influence of hydroxylation position 
and/or shielding of the OH group by adja-
cent atomic groups on the efficacy to increase 
[Ca2+]i. To this aim, we performed a multi-
factorial ANOVA using the mean increase in 
basal [Ca2+]i induced by 20 µM of the differ-
ent OH-PBDEs as the dependent variable. 
Hydroxylation position (ortho, meta, or para) 
and the presence of either one or two shielding 
atomic groups (phenyl ring and/or Br atom) 
adjacent to the OH group were used as fixed 
Figure 1. Molecular structures of (A) the PBDEs (BDE-47, BDE-49, BDE-99, BDE-100, and BDE-153) 
and (B) the metabolites of BDE-47 (6-OH-BDE-47, 6´-OH-BDE-49, 5-OH-BDE-47, 3-OH-BDE-47, and 
4´-OH-BDE-49) investigated in this study. For the metabolites, the position of the OH group is indicated, as 
well as the shielding of this group by occupancy of the adjacent carbon atoms by either phenyl ether and/
or Br atoms. 
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Figure 2. Average and amplitude of [Ca2+]i in PC12 cells exposed to hydroxylated metabolites of BDE-47. 
(A) Cells were exposed to 2 or 20 µM 6-MeO-BDE-47, 6-OH-BDE-47, 6´-OH-BDE-49, 5-OH-BDE-47, 
3-OH-BDE-47, or 4´-OH-BDE-49; note the change in scale. We tested additional concentrations of 6-OH-
BDE-47 (B) and 5-OH-BDE-47 (C) because the 2-µM dose of these metabolites increased [Ca2+]i to > 175% 
of baseline (dashed line). Data are shown from 4–19 experiments per concentration; numbers inside the 
bars indicate the number of cells used for data analysis. 
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variables (Figure 1). A p-value < 0.05 was con-
sidered statistically significant.
Results
Effects of parent PBDEs on [Ca2+]i. Exposure 
to the solvent control [dimethyl sulfoxide 
(DMSO)] or to 20 µM of BDE-47, BDE-49, 
BDE-99, BDE-100, or BDE-153 did not 
decrease cell viability (data not shown) or 
increase the average or amplitude of [Ca2+]i or 
the percentage of cells showing fluctuations in 
[Ca2+]i [see Supplemental Material, Figure 2 
(doi:10.1289/ehp.0901339)]. However, 
the frequency and duration of fluctua  tions 
in [Ca2+]i increased during exposure to 
20 µM BDE-47. At 2 µM BDE-47, simi-
lar effects were observed (NOEC, 1 µM). 
No effects could be detected on the fre-
quency, duration, or amplitude of fluctua-
tions during exposure to 20 µM BDE-49, 
BDE-99, BDE-100, or BDE-153 [see 
Supplemental Material, Table 3 (doi:10.1289/
ehp.0901339)].
Hydroxylated BDE­47 metabolites 
increase [Ca2+]i. After 20 min exposure to 
6-OH-BDE-47, 5-OH-BDE-47, or 4´-OH-
BDE-49, the NR assay indicated a decrease 
in cell viability only at the 20-µM dose, 
with means ± SEs of 86 ± 0.3%, 86 ± 1.1%, 
and 93 ± 0.8% of control, respectively. We 
observed no significant decreases in cell viabil-
ity measured by the NR assay for 6´-OH-
BDE-49 or 3-OH-BDE-47. In the AB assay, 
exposure to 6-OH-BDE-47, 6´-OH-BDE-49, 
or 3-OH-BDE-47 increased the relative fluo-
rescence intensity dose-dependently above the 
control level (data not shown).
Initial increases in [Ca2+]i were observed 
during exposure to 6-OH-BDE-47, 6´-OH-
BDE-49, 5-OH-BDE-47, 3-OH-BDE-47, 
or 4´-OH-BDE-49 [see Supplemental 
Material, Figure 3 and Table 2 (doi:10.1289/
ehp.0901339)]. Exposure to OH-PBDEs 
resulted in a dose-dependent increase in 
average and amplitude of [Ca2+]i with vary-
ing LOECs. LOECs are determined by the 
amplitude of the increase in [Ca2+]i (Figure 2) 
and the percentage of cells showing initial and 
late increases in [Ca2+]i (Figure 3). No effects 
were detected on the average and ampli-
tude of [Ca2+]i during exposure to 20 µM 
6-MeO-BDE-47, and we observed no effects 
of 6-MeO-BDE-47 on cell viability, the per-
centage of cells with increases in [Ca2+]i to 
> 175% of baseline, or the average frequency, 
duration, or amplitude of fluctuations. 
For 6´-OH-BDE-49, 3-OH-BDE-47, 
and 4´-OH-BDE-49, the LOEC for increased 
[Ca2+]i is 20 µM. Exposure to 20 µM 6´-OH-
BDE-49 results in an initial increase in 50% 
of the cells. We observed late increases less 
frequently and with lower amplitude. The 
shapes of the increases in [Ca2+]i during expo-
sure to 20 µM 6´-OH-BDE-49 vary widely 
(Figure 4B). We observed initial increases 
during exposure to 20 µM 3-OH-BDE-47 in 
48% of the cells. Exposure to 20 µM 4´-OH-
BDE-49 resulted in a modest initial increase 
compared with baseline in 83% of the cells, 
after which we observed a larger late increase.
For the OH-PBDEs with an effect at 2 µM 
(6-OH-BDE-47 and 5-OH-BDE-47), we also 
tested lower concentrations (Figures 2B,C, 
and 3B,C), showing that the LOECs for these 
OH-PBDEs are 1 µM. We observed late 
increases only at concentrations ≥ 2 µM. At 
concentrations ≤ 5 µM, this late increase had 
an amplitude comparable to that of the initial 
increase (~ 200–400% of baseline). At 20 µM, 
the late increase induced by 6-OH-BDE-47 
or 5-OH-BDE-47 was much larger [see 
Supplemental Material, Table 2 (doi:10.1289/
ehp.0901339)], which we also observed for 
20 µM 4´-OH-BDE-49. The amplitudes of 
the initial and late increases that we observed 
during exposure to 6-OH-BDE-47 or 5-OH-
BDE-47 were dose dependent (ANOVAs: 
6-OH-BDE-47, initial p < 0.0001, late 
p < 0.0001; 5-OH-BDE-47, initial p < 0.01, 
late p < 0.0001).
The mean amplitude of [Ca2+]i dur-
ing exposure to 20 µM of the hydroxylated 
metabolites was independent of the position 
(ortho, meta, or para) of the OH group on the 
PBDE molecule (ANOVA, not significant). 
However, OH-PBDEs in which the OH 
group was shielded on only one side, with 
either the other phenyl ring or a Br atom, 
induce significantly higher increases in [Ca2+]i 
compared with OH-PBDEs in which the OH 
group was shielded on both sides (ANOVA, 
p < 0.01). However, this influence of the 
shielding of the OH group (on one compared 
with two sides) was independent of its posi-
tion (ortho, meta, or para) on the PBDE mol-
ecule (ANOVA, not significant).
Hydroxylated BDE­47 metabolites 
increase [Ca2+]i by release of Ca2+ from intra­
cellular stores. Although initial increases in 
[Ca2+]i induced by 6-OH-BDE-47, 5-OH-
BDE-47, and, to a lesser extent, 4´-OH-
BDE-49 were reduced in Ca2+-free conditions, 
increases were still observed for all of the 
OH-PBDEs (Figure 4). To identify the respon-
sible Ca2+ stores, endoplasmic reticulum (ER) 
or both ER and mitochondrial Ca2+ stores 
were depleted by either 1 µM thapsigargin 
(TG) or 1 µM TG plus 1 µM carbonyl cyanide 
4-(trifluoro  methoxy)phenyl  hydrazone (FCCP). 
TG and TG/FCCP pretreatment, respectively, 
Figure 3. Concentration dependence of the occurrence of different types of [Ca2+]i disturbances in PC12 
cells during exposure to 2 or 20 µM of hydroxylated metabolites of BDE-47; values shown are the percent-
age of cells showing an initial transient increase or a late increase in [Ca2+]i. (A) Cells were exposed to 
6-MeO-BDE-47, 6-OH-BDE-47, 6´-OH-BDE-49, 5-OH-BDE-47, 3-OH-BDE-47, or 4´-OH-BDE-49. We tested 
additional concentrations of 6-OH-BDE-47 (B) and 5-OH-BDE-47 (C) because the 2-µM dose of these metabo-
lites showed initial and late increases of [Ca2+]i. Data are from 4–19 experiments per concentration; num-
bers inside the bars indicate the number of cells used for data analysis. 
*p < 0.05, **p < 0.01, and #p < 0.001; significant changes in the percentage of cells showing initial or late increases in 
[Ca2+]i are indicated at the LOEC. 
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caused a transient increase in [Ca2+]i of 
321 ± 11% (n = 191) and 393 ± 11% of base-
line (n = 195), after which [Ca2+]i stabilized 
and the OH-PBDE was applied. 
When we depleted ER Ca2+ stores in Ca2+-
free conditions, the initial increase induced by 
5 µM 6-OH-BDE-47 was largely diminished 
(Figure 4A). Although the amplitude of the late 
increase was not different in Ca2+-free condi-
tions, it increased after depletion of the ER Ca2+ 
stores, but greatly diminished after depletion of 
both ER and mitochondrial Ca2+ stores.
We also observed the variation in [Ca2+]i 
responses during exposure to 20 µM 6´-OH-
BDE-49 in Ca2+-free conditions (Figure 4B). 
After depletion of ER Ca2+ stores, we no lon-
ger observed either initial or late transient 
increases in [Ca2+]i. 
Figure 4. Increase in [Ca2+]i by OH-PBDEs results from the release of Ca2+ from intracellular stores. Values shown are amplitudes of [Ca2+]i in PC12 cells during 
exposure to 5 µM 6-OH-BDE-47 (A), 20 µM 6´-OH-BDE-49 (B), 5 µM 5-OH-BDE-47 (C), 20 µM 3-OH-BDE-47 (D), and 20 µM 4´-OH-BDE-49 (E) measured in external 
saline (1.8 mM Ca2+), Ca2+-free saline (0 mM Ca2+), Ca2+-free saline after pretreatment with TG (0 + TG), and Ca2+-free saline after pretreatment with both TG and 
FCCP (0 + TG + FCCP). Cells were pretreated with TG and FCCP to deplete Ca2+ stores in ER and mitochondria, respectively. Tops and bottoms of boxes represent 
upper and lower quartiles, the line within the box is the median, whiskers represent lowest and highest values, and circles represent outliers (for clarity, outliers 
that are more than three interquartile ranges from the boxes are not shown). Data are from three to seven experiments per treatment. Numbers shown in paren-
theses indicate the number of cells used for data analysis; the percentages of responding cells (with increase in [Ca2+]i to > 175% of baseline) are denoted above 
each box. Representative traces of [Ca2+]i measurements of individual PC12 cells exposed to OH-PBDE for 10 min (applied as indicated by arrowheads) in external 
saline (containing 1.8 mM Ca2+) and in Ca2+-free conditions are shown below.
*p < 0.05, **p < 0.01, and #p < 0.001. 
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When the ER Ca2+ stores were depleted, 
the amplitudes of both initial and late 
increases induced by 5 µM 5-OH-BDE-47 
were largely diminished (Figure 4C). After 
depletion of both ER and mitochondrial Ca2+ 
stores, the late increase was further reduced.
We observed mono  phasic increases dur-
ing exposure to 20 µM 3-OH-BDE-47 in 
Ca2+-free conditions, with similar ampli-
tude (Figure 4D). After depletion of the ER 
Ca2+ stores, the amplitude was significantly 
decreased, and even further after depletion of 
ER and mitochondrial Ca2+ stores.
During exposure to 20 µM 4´-OH- 
BDE-49 after depletion of the ER Ca2+ stores, 
the amplitude of the initial increase largely 
diminished (Figure 4E). The amplitude of the 
late increase was not significantly changed in 
Ca2+-free conditions. After depletion of the 
ER Ca2+ stores, the amplitude significantly 
decreased, and even further after depletion of 
ER and mitochondrial Ca2+ stores.
Lower LOECs were identified for hydroxy­
lated metabolites when investigating fluctua­
tions. At LOECs and NOECs based on the 
amplitude of [Ca2+]i, we investigated fluctua-
tions in [Ca2+]i [Table 1; also see Supplemental 
Material, Table 4 (doi:10.1289/ehp.0901339)]. 
We detected no effects on the percentage of 
cells showing fluctuations or the frequency, 
duration, and amplitude of these fluctuations 
during exposure to 2 µM 6´-OH-BDE-49 or 
3-OH-BDE-47. During exposure to 0.2 µM 
6-OH-BDE-47, we observed an increase in 
the percentage of cells showing fluctuations. 
The average duration of fluctuations increased, 
without effects on the frequency or ampli-
tude (NOEC, 0.1 µM 6-OH-BDE-47). At 
1 µM 5-OH-BDE-47, the number of cells 
showing fluctuations increased. Although the 
duration increased, the amplitude and fre-
quency were not affected (NOEC, 0.2 µM 
5-OH-BDE-47). At 2 µM 4´-OH-BDE-49, 
the number of cells showing fluctuations 
increased, as well as the average fluctuation 
frequency, duration, and amplitude (NOEC, 
1 µM 4´-OH-BDE-49).
Discussion
The OH-PBDE metabolite 6-OH-BDE-47 
has previously been shown to disrupt [Ca2+]i in 
PC12 cells by releasing Ca2+ from intra  cellular 
stores at lower concentrations than its parent 
compound BDE-47 (Dingemans et al. 2008). 
The results presented here demon  strate that 
other hydroxylated metabolites of BDE-47 also 
induce Ca2+ release from intra  cellular stores, 
whereas the methoxylated analog (6-MeO-
BDE-47) and the parent compounds lack this 
effect (Figure 2). Experiments in Ca2+-free 
conditions (Figure 4) indicate that the initial 
increases induced by 6-OH-BDE-47, 5-OH-
BDE-47, and 4´-OH-BDE-49 are partly 
caused by influx of extra  cellular Ca2+. The 
initial and late increases induced by 6-OH-
BDE-47 are caused by release of Ca2+ from 
ER and mitochondria, respectively. The 
widely varying increase induced by 6´-OH-
BDE-49 was caused primarily by release from 
ER Ca2+ stores. Both initial and late increases 
induced by 5-OH-BDE-47 and the increase 
induced by 3-OH-BDE-47 are caused by 
release of Ca2+ mainly from ER, but also from 
mitochondria. Both initial and late increases 
induced by 4´-OH-BDE-49 are caused by 
release of Ca2+ from ER, but the late increases 
are also from mitochondria. When investi-
gating fluctuations in [Ca2+]i, we detected 
subtle effects of BDE-47 on the Ca2+ homeo-
stasis and observed lower LOECs for several 
OH-PBDEs (Table 1).
We detected no or mild effects on cell via-
bility for the investigated PBDEs and MeO/
OH-PBDEs, indicating that the observed 
effects on [Ca2+]i were not confounded by 
cyto  toxicity. The AB assay, which is based on 
mitochondrial activity, appeared to be less 
useful in determining cell viability because 
for 6-OH-BDE-47, 6´-OH-BDE-49, and 
3-OH-BDE-47 the relative fluorescence 
intensity increased dose dependently above 
the control level, suggesting induction of 
mitochondrial activity. This may be related to 
mitochondrial uncoupling, which was previ-
ously demonstrated for 6-OH-BDE-47 in 
isolated zebrafish mitochondria (van Boxtel 
et al. 2008).
The low basal [Ca2+]i of PC12 cells is 
maintained by the removal of Ca2+ ions by 
the plasma membrane Ca2+ ATPases and 
Na2+–Ca2+ exchanger (Duman et al. 2008; 
for review, see Westerink 2006). Additionally, 
Ca2+ can be sequestered into organelles, mainly 
ER and mitochondria. Both 3-OH-BDE-47 
and 4´-OH-BDE-49 induce increases in 
[Ca2+]i even after depletion of both ER and 
mitochondria by TG and FCCP. Ca2+ has 
also been shown to accumulate in endosomes, 
lysosomes, secretory granules, the Golgi appa-
ratus, and nucleus (for review, see Laude and 
Simpson 2009). The Golgi apparatus stores 
Ca2+ via sarco  plasmic/ER Ca2+ ATPase pumps 
(Missiaen et al. 2007), which are inhibited by 
TG. Therefore, it is unlikely that release of 
Ca2+ from the Golgi apparatus caused the addi-
tional increase, whereas this remains unclear for 
the other mentioned organelles.
At concentrations not affecting the average 
and amplitude of increases in [Ca2+]i, BDE-47, 
6-OH-BDE-47, and 4´-OH-BDE-49 caused 
an increase in the frequency, amplitude, and/or 
duration of fluctuations in [Ca2+]i. These subtle 
effects on Ca2+ homeo  stasis resulted in lower 
NOECs for most of these brominated flame 
retardants, particularly BDE-47 (Table 1). Ca2+ 
signals vary from micro  domains to globally 
across the cell and from milli  seconds to many 
hours (Laude and Simpson 2009). Because 
the measured [Ca2+]i is an average value for 
the entire cytosol, under  estimation of mem-
brane- or store-associated high [Ca2+]i or high 
[Ca2+]i microdomains (for review, see Cheng 
and Lederer 2008) can be expected. The timing 
of Ca2+ signals, including frequency and dura-
tion, affects how external stimuli cause (patho)
physiologic results (Boulware and Marchant 
2008). Moreover, [Ca2+]i transients trigger 
activity-dependent developmental events in 
neurons, by activating gene expression, cyto-
skeletal elements, or neuro  transmitter release, 
whereas the charac  teristics of these responses 
are determined by amplitude, frequency, 
Table 1. LOECs (µM) of BDE-47 and hydroxylated metabolites for cell viability and different parameters of [Ca2+]i in PC12 cells. 
Ca2+ homeostasis Fluctuations in [Ca2+]i
Decreased 
cell viability
Ca2+ influx 
(extracellular)
Ca2+ release Percent cells  
showing fluctuations
Fluctuation
NOEC ER Mitochondria NOEC Frequency Duration Amplitude
BDE-47 — — — — 20 — 2 2 — 1 (<)
6-OH-BDE-47 20 1 1 2 0.2 0.2 — 0.2 — 0.1 (<)
6´-OH-BDE-49 — — 20 — 2 20a 20a 20a 20a 2b
5-OH-BDE-47 20 1 1 — 0.2 1 — 1 — 0.2b
3-OH-BDE-47 — — 20 20 2 20a 20a 20a 20a 2
4´-OH-BDE-49 20 20 20 20 2 2 2 2 2 1 (<)
—, not detected. For the mechanisms responsible for effects on Ca2+ homeostasis, under “Ca2+ homeostasis,” values shown are LOEC for effects causing a decrease of > 25% in the 
specific Ca2+-free experiments (Figure 4), and resulting NOEC levels. For the investigated parameters of fluctuations in [Ca2+]i, under “fluctuations in [Ca2+]i,” values shown are LOEC 
and resulting NOEC levels; NOEC levels for effects on fluctuations in [Ca2+]i that are lower than NOEC values for effects on Ca2+ homeostasis-related processes are indicated by (<). 
For values of [Ca2+]i and fluctuation parameters, see Supplemental Material, Tables 2 and 3 (doi:10.1289/ehp.0901339). For all PBDEs and MeO/OH-PBDEs investigated in this study, see 
Supplemental Material, Table 4.
aPossible effects on parameters of fluctuations are obscured by release of Ca2+ from intracellular stores. bThe number of data points available to investigate duration and amplitude of 
the fluctuations in [Ca2+]i is insufficient to ensure the NOEC. Dingemans et al.
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source, and spatial location of Ca2+ signals 
(for review, see Moody and Bosma 2005). 
Therefore, the observed effects of OH-PBDEs 
at low concentrations can be of relevance for 
the development of the nervous system.
None of the parent PBDEs except 
BDE-47 showed any effects on Ca2+ homeo-
stasis in PC12 cells. Nonetheless, neuro  toxic 
effects of BDE-47, BDE-99, BDE-100, and 
BDE-153 have been detected at different 
biological levels (Costa and Giordano 2007). 
Because of the lack of effects by parent PBDEs 
in the present study, no effects of bromination 
pattern could be investigated. We confirmed 
that the activity of the OH-PBDEs depended 
on the presence of the OH group, because 
no effects were observed during exposure to 
the methoxylated analog of 6-OH-BDE-47. 
The higher activity of 6-OH-BDE-47 com-
pared with its methoxylated analog is in line 
with other studies, mostly on endocrine effects 
(Cantón et al. 2008; Kojima et al 2009; van 
Boxtel et al. 2008). The mean amplitude of 
increases in [Ca2+]i could not be related to 
the location of the OH group on the PBDE 
mole  cule. However, it appeared that when 
the OH group was shielded on both sides by 
either the other phenyl ring and/or Br atoms 
(as in 6´-OH-BDE-49 and 3-OH-BDE-47), 
the OH-PBDE increased [Ca2+]i less than 
when the OH group was less shielded (as in 
6-OH-BDE-47, 5-OH-BDE-47, and 4´-OH-
BDE-49). Also, the OH-PBDEs with only 
one shielded side of the OH group induced 
release of Ca2+ from ER at the lowest concen-
trations (6-OH-BDE-47 and 5-OH-BDE-47) 
or with the highest amplitude in Ca2+-free 
conditions (4´-OH-BDE-49). Thus, the tox-
icity of OH-PBDEs appears attenuated by 
shielding of the OH group on both sides by 
either the other phenyl ring and/or Br atoms.
Several animal studies confirmed the 
genera  tion of hydroxylated metabolites of 
PBDEs in vivo (Hakk et al. 2009; Malmberg 
et al. 2005; Marsh et al. 2006), and that 
OH-PBDEs were also formed in human liver 
cells exposed to BDE-99 (Stapleton et al. 2009). 
Interestingly, marine organisms have also been 
shown to produce hydroxylated and methoxy-
lated metabolites (Hakk and Letcher 2003).
Only very recently, the occurrence and 
accumulation of hydroxylated metabolites 
were confirmed in humans (Athanasiadou 
et al. 2008), with total OH-PBDE serum con-
centrations up to 120 pmol/g lipids. Another 
study also detected OH-PBDEs in U.S. fetal 
serum samples and confirmed the bioaccumu-
lation of these metabolites (Qiu et al. 2009). 
Moreover, they demon  strated that concentra-
tions of OH-PBDEs were similar or some-
times even higher than the concentration of 
PBDEs. Fetal total OH-PBDE serum con-
centrations ranged from 2.01 to 899.1 ng/g 
lipids (median, 21.96 ng/g lipids). The most 
abundant BDE-47 metabolites found in 
fetal blood were 5-OH-BDE-47 and 6-OH-
BDE-47 (Qiu et al. 2009). It is concerning 
that these metabo  lites caused an increase of 
[Ca2+]i at much lower concentrations than the 
other metabolites of BDE-47 investigated.
All five OH-PBDEs investigated in the 
present study caused Ca2+ release from intra-
cellular Ca2+ stores, although with different 
LOECs. Likely, depending on the position, 
the OH group and adjacent phenyl ether and/
or Br atoms, other hydroxylated metabolites 
of tetra and pentaPBDEs have a similar effect 
on cellular calcium homeostasis. The median 
(21.96 ng/g lipids) and highest (899.1 ng/g 
lipids) concentrations of total OH-PBDEs 
observed in fetal plasma correspond to 
approximately 0.4 and 17.4 nM, respectively, 
in blood (calculated with average physiologic 
parameters). Thus, the highest concentra-
tion observed in human blood is only two 
orders of magnitude lower than the LOEC 
for Ca2+ release from intra  cellular stores by 
OH-PBDEs (1 µM). Moreover, the LOEC 
for increased Ca2+ fluctuations is even lower 
(0.2 µM), meaning that the margin of expo-
sure is insufficient in some individual expo-
sure situations. Also, because OH-PBDEs are 
not associated with lipids—as are the parent 
PBDEs—but have a high affinity for plasma 
proteins (Verreault et al. 2005), the estimated 
blood concentration calculated from expo-
sure values at a lipid-weight–adjusted basis 
(nanograms per gram lipids) may be under-
estimated. However, the LOEC (1 µM) used 
to calculate the margin of exposure is higher 
for other metabolites, and it remains to be 
determined whether the observed effects on 
fluctuations in [Ca2+]i could result in func-
tional or even adverse effects in vivo.
Because exposure to organo  halogen com-
pounds within the time frame of rapid brain 
development can result in behavioral defects 
in mice (for review, see Costa and Giordano 
2007), it is concerning that children are 
exposed to these environmental pollutants 
prenatally and postnatally. Moreover, several 
studies have observed inter  actions between 
environmental pollutants to enhance (neuro)
toxicity. Additive and synergistic neuro  toxic 
effects of polychlorinated biphenyls (PCBs) 
and PBDEs have been detected in vivo 
(Eriksson et al. 2006) and in vitro (Gao et al. 
2009). Concern about possible effects on the 
developing brain arises from the fact that an 
increase in [Ca2+]i by release from intra  cellular 
stores appears to be a common mechanism for 
OH-PBDEs and ortho-PCBs (for review, see 
Mariussen and Fonnum 2006). Therefore, a 
possible additive effect of these environmental 
pollutants with respect to increases in cytosolic 
[Ca2+]i, which not only is a trigger for neuro-
transmitter release but affects many cellular 
processes (Clapham 2007), is not unlikely.
Because very high concentrations of 
PBDEs are occasionally measured in humans, 
the voluntary and legislative measures to reduce 
the release of PBDEs into the environ  ment 
appear justified. Also, hydroxylated metabo-
lites of PBDEs, which were recently found to 
bioaccumulate in humans (Athanasiadou et al. 
2008; Qiu et al. 2009), either from man-made 
PBDEs or of natural origin, are currently not 
taken into account in regulatory human risk 
assessment. The results presented here reveal a 
structure–activity relation  ship for metabolites 
of PBDEs (more shielding of the OH group 
reduces the potency of OH-PBDEs) and rein-
force that oxidative metabolism should be 
included in human risk assessment of persistent 
organic pollutants.
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